Tracked deals
35
35 tracked deals across 2015-2026.
Tracked deals
35
35 tracked deals across 2015-2026.
Buyer mix
Mixed buyer set
24 strategic · 21 pe
Top trend
Volume peaked in 2025
8 tracked deals announced in 2025.
Primary Insight
| Theme seen in Florida deals | Example buyer/transaction |
|---|---|
| Wound care & hemostasis expansion | Merit Medical Systems; BioStem Technologies |
| Diagnostics & point-of-care testing | SSI Diagnostica Group; Premier Biotech |
| Minimally invasive devices | PainTEQ (growth recap); TEAM Technologies (MedTech capabilities) |
| Connected/AI-enabled care | Stryker acquiring care.ai |
Build a buyer list for your Medical Devices deal
Find buyers actively acquiring medical devices companies.
Find buyers like these for your dealBuyer Snapshot
Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.
| Buyer | # Deals | Focus | Type |
|---|---|---|---|
| 3T Medical Systems | 1 | Distributor and supplier of medical consumables and speci... | Strategic (PE-backed) |
| ALPHAEON Corporation | 1 | Social commerce company focused on transforming self-pay ... | Strategic |
| ARCHIMED (ArchiMed) | 1 | Healthcare-focused private equity firm investing in Bioph... | PE |
| ARCHIMED (affiliate of ARCHIMED, via MED Platform II fund) | 1 | Healthcare-focused private equity firm investing across h... | PE |
| Abacus Finance Group, LLC | 1 | Specialty finance firm providing cash flow-based, senior ... | Investor |
| Ajax Health | 1 | Healthcare-focused operating partner that identifies, sup... | Strategic (PE-backed) |
| Align Capital Partners | 1 | Growth-oriented private equity firm investing in lower-mi... | PE |
| Alphatec Holdings, Inc. | 1 | Publicly traded spine-focused medical device company deve... | Strategic |
| Amphenol Corporation | 1 | Global designer and manufacturer of electrical, electroni... | Strategic |
| Arcline Investment Management | 1 | Growth-oriented private equity firm investing in niche, m... | PE |
Last 7 years
Supporting Data
BioStem Technologies (OTC: BSEM) has acquired the surgical and wound care business of BioTissue Holdings, Inc. for approximately $15 million upfront, with up to $25 million of contingent milestone and royalty payments. The deal includes the Neox and Clarix product lines, a nationwide commercial sales organization and assigned GPO contracts, expanding BioStem's access into hospital inpatient and outpatient wound-care markets and adding assets that generated roughly $29 million in 2025.
Premier Biotech, a portfolio company of Align Capital Partners, has acquired National Test Systems (NTS), a provider of rapid point-of-care drug screening supplies and services that serves more than 1,500 facilities across the United States. The acquisition expands Premier's point-of-care testing capabilities (including oral fluid testing) and deepens its presence in government and behavioral health end markets; NTS CEO Andrew Panico will remain involved to support the transition.
ARCHIMED, via an affiliate and its MED Platform II fund, has agreed to acquire NASDAQ-listed ZimVie in a take-private transaction valued at approximately $730 million. ZimVie shareholders will receive $19.00 in cash per share, with the deal expected to close by the end of 2025 subject to customary approvals.
TEAM Technologies, a portfolio company of Arlington Capital Partners, has acquired TAG3 Engineering LLC, a MedTech design, development, and manufacturing firm based in Sunrise, Florida. The add-on expands TEAM Tech's front-end design, regulatory/V&V, and product innovation capabilities to accelerate speed-to-market across cardiovascular, neurovascular and other minimally invasive device markets.
PainTEQ, a Tampa-based developer of minimally invasive sacroiliac (SI) joint implants, completed a majority growth recapitalization co-led by Signet Healthcare Partners and Windham Capital Partners with a new equity investment from MVolution Partners. The capital will fund clinical studies, next-generation product development and expansion of PainTEQ's U.S. commercial presence; transaction terms were not disclosed.
Accelus, a Palm Beach Gardens-based medical technology company specializing in expandable spinal implant technologies, closed a new equity financing round led by healthcare-focused investment firm Concord Health Partners. The capital will support Accelus's U.S. commercial expansion and further development of its spinal implant product pipeline.
Merit Medical Systems has acquired Biolife Delaware, a Sarasota, Florida-based maker of StatSeal and WoundSeal hemostatic devices, in a cash transaction valued at approximately $120 million (including assumed liabilities). The deal expands Merit's hemostasis and wound-care product portfolio and is expected to modestly impact 2025 non-GAAP profitability while enhancing Merit's ability to serve a broad set of percutaneous procedure end markets.
SSI Diagnostica Group (Denmark) has acquired Gulf Coast Scientific, a Florida-based in‑vitro diagnostics company specializing in Urea Breath Testing for Helicobacter pylori. The deal expands SSI Diagnostica Group's gastrointestinal diagnostic portfolio and strengthens its footprint in the US clinical diagnostics market.
Amphenol Corporation has acquired LifeSync Corporation, a developer and manufacturer of disposable and reusable patient monitoring devices sold to hospitals and high-acuity care settings. The transaction marks a full exit for investor Capitala Group (which invested alongside HealthEdge Investment Partners) and supports Amphenol's strategy to expand its healthcare product portfolio and capabilities.
Medical Care Products, a family-owned Jacksonville provider of disposable medical supplies, was acquired by industry veteran Roberto Silberwasser. The sale—handled by Viking Mergers & Acquisitions—transfers ownership from siblings Patricia and Tom Langenbach as they retire and supports continuity of the business.
Stryker announced a definitive agreement to acquire care.ai, a privately held developer of AI-assisted virtual care workflows, smart room technology and ambient intelligence sensors. The deal is intended to accelerate Stryker’s healthcare IT and connected-device capabilities by integrating care.ai’s platform with Stryker’s Vocera solutions and device portfolio.
Bound Tree Medical, LLC has signed a definitive agreement to acquire QuadMed, Inc.; Bound Tree will assume full operation of QuadMed following a 60–90 day integration period. The acquisition brings QuadMed’s pre-hospital care distribution business into the Bound Tree / Sarnova family, expanding the combined company’s distribution network, product and pharmaceutical offerings, and service capabilities for EMS, fire, law enforcement and other first responders.
Argosy Healthcare Partners (AHP) completed a recapitalization and partnership with Command Medical Products, a contract manufacturer of single-use disposable medical devices headquartered in Ormond Beach, Florida. AHP will support Command's next stage of growth while the existing leadership team and founder David Slick remain involved as the company scales production and commercial efforts.
Cadence, Inc. acquired the Florida location of ARC Group Worldwide (ARC Florida) in DeLand, Florida. The acquisition adds Metal Injection Molding (MIM) and cleanroom plastic injection molding capabilities to Cadence’s medtech contract-manufacturing platform, expanding its vertical manufacturing services for medical devices, drug delivery and diagnostics.
Enovis Corporation acquired the SEAL External Fixation (“SEAL”) product business from D.N.E., LLC (DNE). The SEAL line is used in foot and ankle external fixation for conditions such as deformities, fractures, and fusions, and is positioned as an innovative, physician- and distributor-regarded portfolio. England & Company served as the exclusive financial advisor to DNE in the sale.
Alphatec Holdings, Inc. (ATEC) has acquired the Remi Robotic Navigation System assets from Accelus, enabling ATEC to assume Accelus's robotics R&D lab in Boulder, Colorado and transition key Remi personnel. The asset sale lets Accelus refocus on its core implant technologies while providing ATEC with robotic navigation capabilities to accelerate product scalability and commercialization.
EW Healthcare Partners has acquired Germfree Laboratories, Inc., a US manufacturer of turnkey, mobile and modular cleanrooms, biocontainment facilities, and related biosafety equipment and services. The investment will support Germfree’s growth into advanced therapy manufacturing (cell and gene therapy) and help scale its manufacturing capacity from its Ormond Beach, Florida facility with nearly 200 employees.
Palm Beach Capital completed a growth investment in React Health, a Winter Haven, Florida-based manufacturer and distributor of sleep therapy, respiratory therapy and disinfection products. The private equity firm will provide capital and support to help React Health expand product availability and drive innovation for treatment of sleep-disordered breathing and chronic respiratory conditions.
Cornell Capital has agreed to acquire Advancing Eyecare, North America’s leading provider of ophthalmic instruments, from Atlantic Street Capital. The transaction will support AEC’s growth initiatives and accelerate development of its product and service offerings while partnering with the existing management team to scale the business.
One Equity Partners (OEP) completed an undisclosed investment in React Health, a Winter Haven, Florida-based manufacturer and distributor of sleep therapy, respiratory therapy and disinfection products. OEP said the investment will support React Health’s growth and innovation to expand access to diagnosis and treatment for sleep-disordered breathing and chronic respiratory conditions in out-of-hospital care settings.
Smith & Nephew plc has acquired Orlando-based Engage Surgical, a maker of cementless unicompartmental (partial) knee systems, in a transaction worth up to $135 million (contingent payments). The deal, financed from existing cash and debt facilities, secures unique cementless partial-knee technology for Smith & Nephew to support its Robotics and Real Intelligence strategy and growth in the partial-knee market.
Tyber Medical has agreed to acquire all assets of CatapultMD, a precision CNC machining business based in Bonita Springs, Florida. The acquisition will double Tyber's manufacturing footprint to approximately 100,000 square feet, add up to 24 team members and expand its CNC machining capacity for orthopedic implants and instrumentation.
Hellman & Friedman has completed the acquisition of Cardinal Health’s Cordis business for approximately $1 billion, with the buyer assuming certain liabilities and Cardinal Health retaining certain working capital accounts. Ajax Health and Zeus Health are partnering with H&F on the transaction; Cordis will operate as an independent medical device company headquartered in Miami Lakes, Florida.
RTI Surgical has entered a long-term strategic agreement with Exactech and acquired Optecure, a 510(k)-cleared demineralized bone matrix product used as a bone graft extender. The product acquisition expands RTI Surgical’s biologic bone substitute portfolio while allowing Exactech to focus on its core joint replacement business.
3T Medical Systems, a portfolio company of Plymouth Growth Partners, acquired Alternative Exports, Inc., an Apopka, Florida-based supplier of medical, laboratory and hospitality goods. The transaction, announced June 30, 2021 by advisor Woodbridge International, expands 3T Medical’s distribution capabilities and product offerings into new institutional and hospitality channels with backing from Plymouth Growth Partners.
Poverty Dignified, Inc. (soon to be renamed VirExit Technologies, Inc.) has acquired Lexian Products, Inc., the developer of the VIRALUX UV-C disinfection product line. The deal brings Lexian's handheld and mounted UV-C devices into VirExit's antiviral product portfolio to accelerate product development and commercialization of room-scale, human-safe sanitization solutions.
Denver-based private equity firm Mountaingate Capital has acquired BioDerm, Inc., a Largo, Florida manufacturer of disposable medical devices and wound care supplies, in a transaction supported by subordinated debt and an equity co-investment from Five Points Capital and additional financing from Abacus Finance Group. Mountaingate said it will accelerate BioDerm's organic growth and pursue add-on acquisitions to expand product and service offerings while management and founder shareholders retain a continued ownership/board role.
Mirion Technologies, a Charterhouse-backed provider of radiation detection and measurement solutions, has acquired Sun Nuclear Corporation, a global leader in radiation oncology quality assurance headquartered in Melbourne, Florida. The acquisition expands Mirion’s medical portfolio and capabilities in patient-safety solutions for diagnostic imaging and radiation therapy, integrating Sun Nuclear’s hardware and software QA offerings into Mirion’s global platform.
CORE Industrial Partners’ portfolio company Incodema Holdings acquired Mark Two Engineering, a Miami Lakes, Florida-based contract manufacturer specializing in high-precision CNC machining for medical device OEMs. The add-on strengthens Incodema’s nationwide precision manufacturing platform by adding CNC milling/turning/grinding capabilities and expands the combined group's end-market footprint in medical, electronics, aerospace & defense, and industrial sectors.
Arcline Investment Management, a growth-oriented private equity firm, acquired a controlling stake in SYNEO from Rockwood Equity Partners. SYNEO is a vertically-integrated machine, tooling and services company serving the interventional medical device and specialty press-fit PCB markets, with manufacturing facilities in West Palm Beach, Florida and Angleton, Texas and forward-deployed sales/service offices in Europe and Asia.
BVI, a PE-backed global ophthalmic medical device company, has acquired Benz Research & Development and its customized contact lens subsidiary SpecialEyes, both based in Sarasota, Florida. The deal expands BVI's intraocular lens (IOL) materials and contact lens capabilities — leveraging Benz's proprietary molding technology and materials (used in 50+ million implants) to increase IOL production scale and end-to-end capability.
Montagu Private Equity LLP completed the acquisition of the RTI Surgical OEM business (including Tutogen Medical GmbH in related disclosures) from RTI Surgical Holdings, Inc., with the OEM business to operate as a standalone RTI Surgical focused on tissue, biologics and hardware. Montagu will support the business' growth and innovation strategy under President & CEO Olivier Visa following the close in July 2020.
ARCHIMED (ArchiMed) has acquired a 75% stake in ActiGraph in an all-equity transaction, with management retaining 10% and other historic shareholders keeping 15%. The investment will fund ActiGraph's expansion into the regulated drug-development and clinical-trials market, accelerating product, regulatory and commercial capabilities; financial terms were not disclosed.
ALPHAEON Corporation has agreed to acquire substantially all assets of LENSAR, Inc. in a transaction valued at up to $59 million in cash, stock and assumed debt. The deal brings LENSAR’s femtosecond cataract laser technology into ALPHAEON’s lifestyle healthcare portfolio and expands ALPHAEON’s ophthalmology offering for its global network of ophthalmologists.
Leixir Holdings, the Leixir Lab Group network, has acquired the dental laboratory solutions business of Knight Dental Group, Inc. Knight — an ISO 13485-certified full-service dental laboratory based in Oldsmar, Florida — will serve as Leixir's headquarters and center of technical competency as Leixir expands its North American network and market share.
Full Export
Get the full acquisitions list for this page as CSV + XLSX.
Find buyers actively acquiring medical devices companies.
The transactions cover multiple subsectors, including surgical and wound care, hemostatic devices, in-vitro diagnostics and point-of-care testing, implant technologies, pre-hospital distribution, and AI-enabled virtual care workflows.
Recurring buyer names include SSI Diagnostica Group, ALPHAEON Corporation, Mirion Technologies, Inc., Charterhouse Capital Partners LLP, Argosy Healthcare Partners, Arcline Investment Management, Montagu Private Equity LLP, and Cadence, Inc.
Most transactions list Florida, United States for deal location, but buyers may be based elsewhere; for example, SSI Diagnostica Group is identified as Denmark-based while the target is Florida-based.
Yes. The page includes ARCHIMED agreeing to acquire ZimVie in a take-private transaction valued at approximately $730 million (deal expected to close by the end of 2025, subject to approvals).